Inhibition of proteasome activity blocks the ability of TNF alpha to down-regulate G(i) proteins and stimulate

L M Botion1, A R Brasier, B Tian

  • 1Depto de Fisiologia e Biofísica-Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil 31270-901.

Endocrinology
|November 20, 2001
PubMed

Insights

Tumor necrosis factor alpha (TNF alpha) and N(6)-phenylisopropyl adenosine (PIA) increase fat breakdown (lipolysis) by reducing inhibitory G proteins (G(i)). Proteasome inhibition blocks this effect, indicating proteolysis is key to TNF alpha and PIA-induced lipolysis.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Molecular Pharmacology

Background:

  • Tumor necrosis factor alpha (TNF alpha) and N(6)-phenylisopropyl adenosine (PIA) promote lipolysis in adipocytes.
  • This lipolytic effect is partly mediated by the down-regulation of inhibitory G proteins (G(i)).
  • The precise mechanism of G(i) down-regulation and its role in lipolysis requires further investigation, particularly concerning proteolysis.

Purpose of the Study:

  • To investigate the role of proteolysis in TNF alpha and PIA-induced G(i) down-regulation.
  • To determine if proteasome or calpain pathways are involved in the lipolytic effects of TNF alpha and PIA.
  • To elucidate the mechanism by which TNF alpha and PIA stimulate lipolysis.

Main Methods:

  • Rat adipocytes were treated with TNF alpha or PIA following preincubation with proteasome inhibitor lactacystin or calpain inhibitor calpeptin.
  • Lipolysis was quantified by measuring glycerol release.
  • G(i) protein alpha-subunit abundance was assessed using Western blotting, and protease activities were measured via fluorogenic assays.

Main Results:

  • Both TNF alpha and PIA significantly increased lipolysis and down-regulated G(i) protein levels.
  • Lactacystin completely inhibited TNF alpha and PIA-stimulated lipolysis and G(i) down-regulation.
  • Calpeptin had no significant effect on basal or stimulated lipolysis or G(i) down-regulation.

Conclusions:

  • The lipolytic effects of TNF alpha and PIA are dependent on the down-regulation of inhibitory G proteins (G(i)).
  • Proteolytic degradation, specifically via the proteasome pathway, mediates the down-regulation of G(i) in response to TNF alpha and PIA.
  • These findings highlight the proteasome pathway as a critical component in regulating adipocyte lipolysis.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...